Semaglutide, tirzepatide, and the oral GLP-1 agonist orforglipron are being evaluated in clinical trials for pediatric populations

Biological preparations that stimulate the immune system to recognize and protect against infectious diseases by inducing a targeted immune response.

Supports optimization of metabolic function through nutrition, monitoring, and lifestyle guidance.